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SUMMARY 
The trypsin fragments of rat liver microsomal cytochron1e b5 (Tb:;) Iack 
both methionine (met) and cysteine (cys), i.e., the sulphur-containing antino 
acids. Tb15 should therefore contain no 358-radioactivity after isolation from 
animals treated wHh [35S]met or [36S]cys. If, however, the nucleic acids coding 
for this polypeptide have been damaged by a genotoxi~ cart:inogen, a misco-
ding could result in an incorporation of met or cys into the polypeptide so 
that Tb8 could now be 368-radiolabelled. Two experiments are descrihed. the 
ftrst one where a toxic regimen of N -nitrosomorpholine (NNM) to rats 
resulted in a significant increase of 358-radioactivity in the Tbs of Jiver 
microsomes, and a second experiment with a non-toxic regimen of N.N-
dlethylnitrosamine (DENA), where no increase was observable. 
Key wurds: MammaJian mutagenicity test- Pointmutation-Protein coding-
Cytochrome ~,.,-Amino acid composition- Rat Ii ver microsomes 
---------
INTRODUCTION 
It is now widely acccpted that mammalian mutagens are carcinog;ens. and 
a number of sbort·terna tests for carcinogenicity base upon the deternlination 
AbbreviationA: Tbll, trypsin fra~t;ment of cytochrome bs: met. L-methionine; c~·s. 1.-c..·ysteine: ilt>. 
L·isoleucine; NNM, N·nitrosomorpholine; DENA. N,N-diethylnitrosamin~; 06~G. 0,;-ethyl-
guanine. 
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of a mutagenicity of a test compound [1). Very recently it has been reported 
that a single point mutation of guanosine to thymidine was the only genetic 
cbange required to activate the oncogene in T24 (2) and EJ (3) human 
bladder carcinoma cells. These findings exemplify that an aa.ay for point 
mutations might represent a valid approach to the testing of potential 
carcinogens. 
Many tests for mutagenicity are performed in vitro although it ia evident 
from a number of reports tha.t the activation of mutagen& to the ultimate 
genotoxic form and the subsequent inactivation to detoxified compounds does 
not reflect the in vivo situation [4}. Therefore, there is a need for in vivo tests 
for mutagenicit~'· and we report. here on a novel application of the amino acid 
substitution assay suggested by Popp et al. (5). 
The trypsin fragments of rat microsomal Tbt; Iack both met and cys, i.e., all 
sulphur-containing amino acids (6). Tbll isolated from rat liver microsomes 
should therefore contain no 35S.radioactivity if the animal has been ad· 
ministered [35S)met or (35S)cys. lf. however, the gene coding for this polypep. 
tide is damaged by a mutagen, a point mutation could result from miscoding 
so that the daughter cell gcne could code for met or cys. Consequently, 
mRNA transcribed from a damaged gene could contain a substituted base 
and Iead to the incorporation of met or cys into the polypeptide chain so that 
resulting Tb5 now would exhibit 358-radioactivity. Similarly, mRNA tran· 
scribed from a normal gene could also be damaged by the mutagen and 
contribute to the Ievel of met or cys in Tb6• 
We describe the results of tw(t experiments, the first one where a toxic 
regimen of NNM resulted in a significant increase of ~ms.radioactivity in the 
Tb5 of rat liver microsomes. In a second experiment with a non-toxic regim~.~n 
of DENA, the increase in 358-radioactivity was no Ionger detectable. 
MATERIALSAND METHODS 
Animals and chemieals 
Male rats [ZUR:SIV ·Z, Sprague-Dawley derivedl were used. They were 
held three per Macrolon cage on laboratory chow No. 890 (Nafag AG. Gossv.•~ 
CH) and tap water ad libitum. L·[3&S]met of an original speciftc activit~, of 
1061 and 1000 Ci/mmol and L-(4,~·3H(N)]ile (84 Ci/mmol) were purch.ased 
from New England Nuclear. NNM and DENA were from Fluka AG, Buchs 
CH. Aminosol, a 10tH.-' hydrolysate of casein, cx•:ip. ad infundib. wa:f from 
'Vitrum AB, Stockholm, Sweden. All other rea1tents werc of the highest 
purity available from Merck, Darm.-;tadt, F.R.G. 
Liquid scintillation counting 
Sampies were counted in Insta·G~l cocktail (Packord) in low background 
glass vials (Packarrl) in a Packard 'fri Carb 460 CD scintillation countcr. 
Experiment 1. Three 5-6-week-old rats (rat nos. 4, 5 and 6) werc treated for 
1 ß weeks with 100 mg/l NNM in the drinking water. After 7 weekK with?ut 
treatment, the animals reccived a single oral dose of 53.1, 99.7 and 
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139.6 mg/kg NNM, respectively. Eight hours thereafter. food was withdrawn 
in order to synchronize subsequent protein synthesis which was initialized 
24 h after the carcinogen treatment with the administration of 5. 7 mCi/kg 
(35S)met and 27 1J. Ci/kg l3H)ile in 6.2 ml/kg of an aoueous solution of amino 
acida (aminosol 10%) and sucrose (16%). After 24 h,· the animals were killed 
and the livera were processed immediately. Three control rats (nos. 1 .. 2 and 
3) received tap water in the place of allcarcinogen treatmP".tb. 
Experiment 2. Three 5-6·week·old rats were treatea for 6 weeks with 
20 mg/1 DENA .in tbe drinking water. After 2 days without treatment, thP 
animals received a singleoral dose of 37.7, 36.1 and 38.7 mg/kg DENA. Eight 
hours thereafter. food was. withdrawn in order to synchronize subsequent 
protein synthesis which was initialized 24 h after the carcinogen treatment 
with the administration of 7.66 mCi/kg (35S)met and 26.9 p. Ci/kg [3H]ile in 
6.26 ml/kg of an aqueous solution of amino acids (aminosol 10'-Yl') and sucrose 
(16%). After 24 h. the animals were killed and the livers were processed 
immediately. Three control rats received tap water in t.he place of all 
carcinogen treatments. 
Isolation of the trypsin fragments of liver m icrosomal cytoch rome bs 
A Ii ver homogenate was prepared acc. & ding to Omura et al. [7]. The 
incorporation of 368-radioactivity into whole liver protein amounted to 12.5t;f· 
and 11.3% of the administered Iabel. The microsomal fraction [7] exhibited a 
specific radioactivity of 5.86 · 105 and 4.0 · 105 dpm [358]/mg rnicrosomal pro· 
tein (Expt. 1 and 2, respectively). The subsequ~nt isolation of Tb5 also 
followed an established method [7], modified as follows: 
A Sephadex G 100 SF <I'harmacia) C01 1tmn (2.5 x 35cm) was used and 
eluted with 50 mM NaCI/50 mM Tris-HCI (iJH 7.5). Ionexchange chromato· 
graphy was performed on a DEAE Sephacel (Pharmacia) column (1.5 )~ 6 cm). 
with a linear salt gradient of 100 mM NaCl/50 mM Tris-HCl to 130 mM 
NaCI/60 mM Tris-HCl (pH 7.5) with a total volume of 250 ml. Fractions 
exhibiting an absorbance ratio 413/280 nm of more than one were pooled. 
diluted with an equal volume of water, loaded on a second DEAE Sephacel 
column and eluted as before. Further purification and sepa:t·ation of different 
tryptic peptides was obtained with repeated hydroxylapatite (Bio-Rad) 
column chromatography as described [6] but with the following modifications: 
DEAE Sephacel eluent fractions exhibiting an absorbance ratio of ~a \\'ere 
concentrated and desalted on a Amicon M52 ultrafiltration system with a 
Diafto YM5 membrane. The concentrate was loaded on a hydroxylapatite 
co!umn (1.5 x 6.5 cm) and eluted with a linear phosphate gradient from 5 to 
100 mM (pl{ 6.7) total volume 250 ml. The second hydroxylapatite column 
(1.5 x 9 cm) was eluted with a 50-100 mM phosphate gradient for the frag. 
rnent eluting with 75 mM phosphate and with a 35-85 mM phosphate 
gradient for the fragment eluting with 58 mM phosphate. Total votume \\ras 
200 ml. Fractions containing Tb5 WHre pooled .and ultrafi ltrated as described 
above. 'rhe amount of 1'b6 isolated was .ietermined on the basis of the op·tic:al 
density at 413 nm (E4tanm = 117 mM· 1 cm 1). The purity was characterized by 
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the ratio of the optical densities at 413 and 280 nm. Sodium dodecylsulphate 
polyacrylamide gel electrophoresis in a 3-mm slab was the final purification 
step. A 4% stacking gel and a 15% separation gel was used. Tb& was loaded in 
a 3-cm wide slot and located with Coomassie Blue R Brilliant. 
For liquid scintillation counting of the bands, the gel was digesttd as 
follows: In experiment 1, gel slices (3 mm x 3 cm x 1 cm) were cut into small 
pi~es and swollen for 24 h at 50°C with 1.2 ml water and 0.6 ml soluene-350 
tissue solubilizer (Packard) in a Toluene/'rrit.on X-100 bas~d scintillation 
liquid. In Expt. 2, the stained gel slices \\"·ere incubated with 80 mg 60% 
perchloric acid and 800 J.Ll 30% hydrogen peroxide and digested at 70°C in a 
shaking water bath for 14 h in glass tubes closed with tefton-lined screw caps. 
The resulting clear solution was partially neutr·alized with about 30 mg 27% 
sodium hydroxide to a pH of 2-3. After addition of 8 ml Insta-Gel and 1 ml 
water, tbe mixturewas shaken vigorously to yield a homogeneous sample for 
liquid scintillation counting. A slice of gel taken from the side of each slab 
was also digesttxl and tbe radioactivity count was used as a background value 
for the samplcs run in each slab. The background in the tritium channel 
ranged from 21.4 to 24.6 cpm, and 26.0 to 32.7 cpm in Expt. 1 and 2, 
respectively, the 358-values were 18.3-18.5 and 11.1-11.8 cpm, respectively. 
Slices cut from the sample slots above or below the stained protein 'band did 
not contain any measurable radioactivity. 
RESULTS 
Figures 1 and 2 summarize yield and purity of Tb5 during the isolation 
procedure in Expts. 1 and 2, respectively. In Expt. 1, it is conspicuous that the 
carcinogen-treated animals yielded a much lower amount of total microsomal 
protein and Tbs. The specific radioactivities of microsomal protein and Tb& 
((3H]ile) were, however not different (Table n. This means that the rate of 
cytochrome b& synthesis was not affected by the carcinogen treatment. 
Tb5 contains the heme moiety of cytochrome b5, which absorbs light at 
413 nm in the oxidized state. The UV· absorbance at 280 nm is general for 
protein. The absorbance ratio 413 nm/280 nm can therefore be taken as a 
criterion for purity and Iiterature values of 6.35 (6] are given for their purest 
Tbs preparations. Our samples reached theselitersture values already after 
hydroxylapatite chromatography. For our purpose, it was of prime im· 
portance to minimize contaminations by proteins containing [36S]met. There· 
fore, an additional purification step by sodium dodecylsulphate polyacryl-
amide gel electrophoresis was performed. lt was not surprising that no 
contaminating protein band was visible on the gel, although up to 12 nmol 
(about 120 p.g) Tb5 Wfire applied per slot. 
Trypsin digestion of cytochrome b6 is known to yield two fragments 
containing 82 and 88 amino acids and it has been shown that the Ionger 
fragment can be converted to the smaller upon more extensive incubation 
with trypsin [6). Aseparation is achieved only by phosphate gradient elution 
from hydroxylapatite with ionic strengths of 58 mM and 75 rnM phosphate 
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Fig. 1. Yield (left-hand ordinate) and purity (right-hand ordinate) of the trypsin fragment of 
cytochrome b& (Tbs) isolated from rat liver microsomes without (1-3) and with (4-6) pretreat-
ment of the animals with NNM (Expt. 1; see Materials and Method~ for treatment schedule-). 
ODR, ratio of optical densities at 413 and 280 nm. 
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Fig. 2. Yield Oeft-hand ordinate, sum of both fragments} and purity (risht-Jtand ordinate. 
average of both fragments) of the trypsin fragments of cytochrome bs (Tbs) isolated from rat 
Ii ver microsomes without (1-3) and with (4-6} pretreatment of the animals with DENA (Exr~ ~: 
see Materialsand Methods for treatment schedule). ODR, ratio of optical densitiPs at 413 and 
280nm. 
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TABI.-E I 
INCORPORATION OF (35SJMET AND [SH)ILE INTO THE TRYPSIN FRAGMENTS OF RAT LIVER 
MICROSOMAL CYTOCHROME b5• WITH OR WITHOL'T PRETREATMENT WITH THE HEPATO. 
CARCINOGEN NNM 
Treatment 
Controls Cattinogen-treated 
Animal no. 2 3 4 5 6 
.... ' ............ ""'" _... ··-·-·_...-..._.._ .. _____ 
P~Simel udminilltered 5.59 5.63 5.75 5.67 5.83 5.83 
CmCilkg) 
flHiiw administered 26.4 26.6 27.3 26.9 27.7 27.6 
(pCi/kg) 
ßody wt. at time of 568 564 550 565 614 619 
sacrifice (g) 
l .. iver wt. (g) 21J.I 20.1 20.6 21.4 16.3 15.9 
Tb~ yield in mitrosomes 0.941 0.991 0.878 0.569 0.577 0.576 
(nmol/mg protein) 
:•u.spec:. act. 0.613 0.579 0.641 0.575 0.645 0.626 
Cdpm/nMol Tb:;lp Ci ile/kg) 
Amount of Tb5 in 7.95 10.8 11.5 0.89 5.03 2.70 
scintillation via! (nmol)8 
Tutal count. 3Hoochannel 55.1 62.8 66.4 28.1 39.0 32.7 
(~pm. 4 · 40 min counting) 
Totalcount 358-u:hannel 19.80 19.65 19.54 18.92 19.58 19.42 
(c:pm. 4 · 40 min counting) 
Sptae. act. Tb~ 16.5 15.4 17.5 16.5 17.9 17.3 
PHJ <dpm/nmol)11 
Spec. act. T~ 0.32 0.21 0.20 0.99 0.·17 0.77 
I~S)channel (dpm/nmol)b 
Ratio 36SJ3H 0.019 0.014 0.012 0.064 0.026 0.045 
(dpmidpm)b 
Mean .t S.D. 0.015 :t 0.004 0.0;&5 :t 0.019 
P for tht- hypothesis of equality (t.test) ,_- 0.02 
tone-sided and on the hasis 
of the logarithms of the single values) 
•caJcuJated on the basis of the 3H counts and the specific activit.y as determined after hydroxylapatite 
column 2. 
bCounting efficiency about 22.3c.f. for 3H. 52.9% for 36S. 
for the elution of tbe Ionger and shorter fragment, respectively. The relative 
amounts of the two fragments strongly varied. ln Expt. 1, rat no. 1 yielded 
almost exclusively the Ionger fragment whert~as all the otber isolations 
resu lted in much shorter fragments. ~ n Expt. 2, both fragments could be 
isolated in substantial amounts. They could be processed separately after the 
first hydroxylapatite column. Since both fragments are equally suited for our 
assay ·- tbey do not differ with respect to the presence of 4 ile and the Iack of 
sulphur-containing amino acids [6]- mutual contaminations do not interfere 
with the interpretation of the 35SJ3H-activity ratio. 
[ 3H)ile was administered simultaneously with [36S]met in order to have an 
internallabel in the newly syntbesized protein. For a comparison of the 
35S·radioactivity of Tbs isolated from treated versus control aniD"!als it was 
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TABLE II 
INCORPORATION OF [Sig]MET AND ['H]ILE INTO THE TRYPSIN FRAGMENTS OF RAT LIVER 
MICROSOMAL CYTOCHROME ba. WITH OR WITHOUT PRETREATMENT WITH THE HEPATO· 
CARCINOGEN DENA 
Treatment 
·-- ··-·-·-···--···- ·-·--· . 
Controls Carcinogen-treated 
__ ... _____ .. _"'""•-- -. 
Animal no. 2 3 4 5 6 
... ---·--------···--
l'&slmet administered 7.13 6.95 7.49 8.03 7.95 ~.n~ 
(mCi/kg) 
[3H)ile administered 25.1 24.4 26.3 28.2 28.0 :Jo a 
(J.tCi/kg) 
Body wt. at time of 369 354 a33 317 32:3 :11 !l 
sacritlce (g) 
Liver wt. (g) 17.1 14.4 12.9 12.2 IO.R Hl.5 
Tb11 yield in microsomes 0.749 0.689 1.112 0.790 0.926 0 ril:! 
(nmol/mg protein) 
(3 H]spec. act. 0.501 0.322 0.401 0.496 0.350 0.:?.21" 
(dpm/nmol Tbr,/#J Ci ile/kg) 
Amount of Tb5 in vial 5.62 7.97 11.16 
_., 6.18 1:! :!t) 
(nmol)• 2.60 8.77 3.13 3.92 6.61 6 ~:J 
Total count 3H-channel 52.6 45.4 62.4 -'9.2 .1) 7 
(cpm, 4 · 40 min counting) 43.1 55.8 39.5 47.5 49.2 4M l 
Total count 35Schannel 16.1 15.17 18.17 14.93 tr. (;'. 
(cpm, 4 · 40 min counting) 14.15 20.25 13.58 1~.48 15.:15 1 ti :,!,=) 
Spec. act. Tbr, 12.6 7.9 10.6 14.0 9.~ ti9 
(3H] (dpm/nmol)r.d 
Spec. act. Tbli 1.37 0.65 0.88 tJ.% 11_.1:.! 
[ 35S)chann. (dpm/nmolY·@ 1.69 1.57 1.11 2.82 0.94 1 l:! 
Ratio 36Sf3H 0.109 o.o8:i 0.083 O.tl9~ l.llltll 
(dpm/dpm)" 0.135 0.200 0.105 O.:lO 1 o.n9t; ll lt):! 
Means~S.D. 0.119:::0.044 0. 124 • t) tl!l-:' 
P for the hypothesis of equality (t-test) 0.89 
•First line: Tb5 fragment of 82 amino acids; Ree'ond line: Tb6 fragment of 88 amino arids Amount 
calculated on the basis of the 3H counts and the specific activity as deterrnint'd after h~·drox~·lapättte 
column 2. 
bShorter fragment lost be.~ause of malfunctioning of fraction collector. 
c Counting efliciency 28.9% for 3H, 64.8% for 3SS. 
dThe specific activity was determined after hydroxylapatite 2 and was about tht- sanw fl1r bllth try~tn 
fragments of cytochrome bs. 
'The difference between the two fragments is probably due to cl1fferences in protein contamincHtu:b 
therefore not necessary to have equal amounts of Ths in the sc:ntillation vial 
or equal rates of protein synthesis in the liver, but it was possible to compare 
the ratio 35Sf3H which was expected to be higher if a mutation leading to the 
incorporation of met had occurred afte!r carcinogen treatment. 
Table I compiles the experimental details for Expt. l. The J~sr~H ratio5 
were indeed higher in the carcinogen-treated rats. Statistical analysis of the 
data with a one-sided Student's t-test revealed a Ievel of significance of 
<0.02. Tb5 isolated from control animals did also contain a minute :15S-
radioactivity, probably due to traces of contaminating protein. We cannot. 
therefore, exclude, the theoretical possibility that. the difference in the J!\SPH 
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ratio between carcinogen-treated and control animals could also be based 
upon higher protein contaminations in the Tb5 isolated from the treated 
group. However, we cannot find any scientific basis for such a bypothesis, and 
therefore consider this possibility much less likely than the generation of 
sulphur-containing Tbs variants. 
It was tbe aim of this first experiment to find out whether the assay works 
at all. We therefore chose a very drastic carcinogen regimen. The treated rats 
had a severely damaged liver. The livers bad necroses and histological 
examination revealed preneoplastic and neoplastic foci. Thanks to the fact 
that the rate of protein biosynthesis was not different in the two groups, this 
observation should not confound our analysis of the data. 
On the basis of the promising results with this first experiment, a second 
experiment was carried out with the following modifications: Instead of 
NNM, the ethylating agent DENA was used because this carcinogen is 
known to give rise to a relatively large proportion of 0 6-guanine ethylations 
(8] kn1J1wn for their miscoding properties [9]. The doses used were much lower 
so as not to induce any liver darnage [10]. And thirdly, the isolation of Tb5 
was speeded up so that 62% of tht! initial 358 specific activity was available at 
the time of the measurement of the radioactivity on Tb5. Table II summarizes 
the results. The 35Sf3H ratio is only marginally higher in the treated group. 
The nucleic aciddarnage produced in the second experiment therefore did not 
result in any observable increase in misincorporations. 
DISCUSSION 
A number of different events can Iead to the incorporation of the 'wrong' 
amino acid methionine into newly synthesized Tb5• DNA damaged by the 
carcinogen could either Iead to a mutated daughter cell, now expressing a 
met in Tb5 or be transcribed to •a. mutated mRNA molecule coding for met. 
Furtht'rmore, the alkylation of mRNA by the carcinogen f!ould Iead to a 
n1iscoding du ring translation and incorporation of met into the protein. In 
addition, there are a number of possibilities arising from an alkylation of the 
anticodon of the tRNA or of the enzymes involved in replication, tran· 
scription, or tra.nslation, i.e. also from non-mutational events. 
The carcinogen treatment of the animals was both chronic and acute in 
order to increase the possibilities for an incorporation of met. The long-term 
treatment of the rats with the carcinogen was meant to generate mutated 
cells containing a DNA cocling for a met in Tb6• Such a cell c:an be viable and 
produce fun<~tional cytochrome b5 as is nicely shown in man, where the amino 
acid 7 4 is n1ethionine, whereas all animal species examined have leueine at 
this position [11]. This replacement of a neutral amino acid by another 
neutral one would leave the ch:romatographic properties of the polypeptide 
largely unchanged so that the altered Tb5 chain would not lbe lost during the 
isolation procedure. 
An acute dose of the carcinogen was given 24 h before tJne administration 
of the radiolabelled amino acids. This treatment was meant to acutely 
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alkylate DNA and RNA so that DNA-mRNA and mRNA·tRNA miscodings 
could occur. 
It is tempting to speculate whether th(e limit of detection in our experi-
ments was anywhere near the frequency of miscodings to be expected from 
the carcinogen treatments. We do not see i!l way for a reliable approximation 
of the met yield to be expected from DNA-DNA mutations. The consequence 
of DNA-mRNA and mRNA-tRNA miscodings arising after -the acute car· 
cinogen treatment in Expt. 2 should be better amenable to an estimation: the 
single dose of 38 mg/kg DENA has resulted in about 38 ethylations per 106 
DNA nucleotides, as can be calculated from the appropriate bind~ng data 
[12]. Of the total number of ethylations, only about 9o/C are at ~he 0 6 of 
guanine. resulting~ in a critical premutagenic lesion [8]. Taking into account 
that guanine represents 22o/o of all DNA bases in the rat, the chance for a 
guanine to become an 0 6-eth.ylguanine (06eG) therefore was: 38 · 0.09 · 
10-8/0.22 = 1.56 · 10-5• Only a fraction of all possible amino acid sub-
stitutions by DNA-mRNA and mRNA-tRNA miscodings Ieads to the in-
corporation of met. For instance, 0 6-ethylation of a guanine of a DNA codon 
for threonine (T08eGC) could result in an l\UG triplet in the mRNA 
synthesized. This AlJG triplet would result in :1 met incorporah.'d intü tht· 
polypeptide chain. Taking into account the nurober of threonine residut:•s in 
Tb5 (=6), the multiplicity of codons for thr (=4), and the chanl·e rur a guanint· 
to become an 0 6eG ( = 1.56 · 10- 5), the estirnated frequenc.v of this even t i~ 
about 6 · 1/4 · 1.56 · 10-5 = 2 · 10- 5 per Tb5 gene. Similar calculations with ile-. 
arg· and Ieu-met replacements will result in a total frequency of about 
3 · 10-5 so that about one out of 33000 newly synthesized Tb5 molecules is 
expected to contain a met. This frequen~y would result in 0.08 dpm :l5S-
radioactivity in a vial containing 6 nmol Tb5 isolated from a carcinogen-
treated animal. This value was estimated on the basis of the experimentally 
found [3H]ile a(:tivity in Tb5 (10.3 dpm/nmol), the amount of Tb5 isolated. the 
ratio of the frequencies for met and ile (4 per Tb5 molecule), respectively. 
taking into ac·count .that 280 times more P5S]met radioactivity has been 
administered and correcting for the decay of 35Suradioactivity during the 
isolation procedure. The calculation therefore was: 10.3 · 6 · 1/4 · 280 · 
0.65/33000 = 0.08 dpm . 
. Our experimental Iimit of detection is primarily dependent on the amount 
of Tb5 synthesized during the presence of radiolabelled precursor amino acid 
and put into the scintillation vial, on the a.mount of 35S-radioactivity ad· 
ministered, and on the purity of the isolated 'fb5• In thP second experiment. 
this experimental Iimit was about 45 times above our theoretical Iimit. 
because only an increase of 3.6 dpm 35S-a,!tivity would have led to a 
signif1cantly different population of 35SPH values cornpared with the controls. 
It must, however, be added that a large numbe~r of possibilities that can also 
Iead to an incorporation of met into Tb5 cannot be estimated quantitatively ~o 
that only the e:~periment could answer the question about the Iimit of 
dettection. One important mechanism by which the 3·;8-radioactivity could b() 
effectively increased, is the possibility that one of the mutated cell.:; mi~ht 
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have grown into a group of mutated progeny or even into a hyperplastic 
nodule ol · .. t neoplastic lesion. This could be one of the reasons why the 
respective effect was observable only in the high-dose Expt. 1. 
Changes in amino acid composition of peptides as a result of treatment of 
animals witb cbemical mutagens are recently being studied more often, 
primarily with protein mapping on two-dimensional gel electrophoresis 
(13,14]. We are, however, not aware of any breakthrough in the risk assess· 
ment of exposure to chemical carcinogens on the basis of this type of 
approach. The assay described here has a number of general advantages over 
the mapping procedures: (i) Organ specificity of mutagens can be followed 
directly with the assay described here because cytochrome bs is present in 
most tiseues [15]. (ii) The determination of the number of point niutations 
tnduced _-:-.r.d~· allow a quantification of the mutagenic and probably also 
eal'~inogenic potency of a genotoxic chemical. So far, only in vivo assay of a 
DNA darnage seems to produce a reasonably good correlation with car-
cinog~~nic potency [16], but does not fully take into consideration DNA repair 
or the mutagenicity of the many types of DNA damage. With the present 
somatic mutation. assay, these two important modulatory inftuences are 
included in part so that ai correlation with carcinogenic potency should be 
much improved. In addition, there is no need for radiolabelled test compound 
as is the case with DNA binding. 
In conclusion, this assay system could show a way for the detection of 
somatic point mutations in vivo. With the yield of pure Tb5 as obtained in 
these experiments, only high dose exposure to a carcinogen was detectable. In 
order to lower the sensitivity of this assay. it seems worthwhile to improve 
the isolation procedure for Tb5 or to search for other proteinB with amino acid 
compositions that could lend to this type of assay. 
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